| Literature DB >> 29618902 |
Md Kamrul Hasan1, Saruar Alam1, Jovan Mirkovic2, Md Faruk Hossain2.
Abstract
Previous studies showed that prolonged exposure to fluoride (F-) and aluminum (Al3+) ions is associated with numerous diseases including neurological disorders. They don't have any known biological function. But they can bind with proteins that interact with ions similar to them. Such unwanted interactions affect the normal biological function of the target proteins, as well as their downstream protein-protein interactions. Several studies show the detrimental effects posed by them including Alzheimer's disease. However, their target proteins have never been reported. Here, we have screened for the human protein targets subjected to F- and Al3+ interactions by using data-driven prediction tools. We have identified 20 different proteins that directly bind with them (10 interact with fluoride and 10 with aluminum). In addition, protein-protein interaction has been explored to find the proteins that indirectly interact with F- and Al3+. We have found 86 indirect targets for F- and 90 for Al3+. Furthermore, 19 common protein targets have been identified, including proteins (9 out of 19) associated with neurodegenerative disorders. However, wet lab experiments are beyond our scopes to validate the binding networks. Additional studies must be warranted.Entities:
Keywords: Aluminium; Fluoride; Human Health; Neurodegenerative disorders
Year: 2018 PMID: 29618902 PMCID: PMC5879948 DOI: 10.6026/97320630014068
Source DB: PubMed Journal: Bioinformation ISSN: 0973-2063
Figure 1The network of interactions of (a) fluoride and (b) aluminum with protein targets predicted by STITCH 5.0. Fluoride and aluminum are represented as pill-shaped nodes, while proteins are shown as spheres. Nodes that are associated with each other are linked by an edge. The line's length refers to the binding affinities with each other. Greater affinity means shorter edge between the chemicals and the proteins and vice versa.
List of all proteins that directly and indirectly interact with fluoride. Analyzed by STITCH 5.0 and STRING 10.5 tools.
| STITCH | CALM1 | CALM2 | BCHE | AQP6 | NUDT3 | BGLAP | GAPDH | TP53 | ENO2 | ATP11A |
| STRING | MYLK | FGF12 | COLQ | TOP2A | SOX30 | GGCX | ALDOA | ATM | GPI | ATP7A |
| NOS1 | PPP3CA | DOK7 | TOP2B | MYCBP2 | FURIN | ALDOB | CDKN1A | PGAM2 | PRDM10 | |
| NOS2 | CAMK2A | CHRNA4 | GK | MGAM | SPP1 | ALDOC | CDKN2A | PGAM4 | WDTC1 | |
| NOS3 | CAMK2B | CHAT | GK5 | RPS10 | BMP2 | PGK1 | MDM2 | PGAM1 | ATP7B | |
| PPP3CA | NOS3 | APOE | SHPK | AP1S2 | RB1 | TPI1 | MDM4 | GAPDH | ATP1B2 | |
| PPP3CB | CAMK2G | F2 | GPD2 | TBP | BPGM | BAX | PGK1 | ATP1A3 | ||
| PPP3CC | SPTAN1 | ALB | GK2 | RUNX2 | PGK2 | BCL2 | PGK2 | ATP6V1A | ||
| CAMK2A | SCN10A | APP | AQP10 | IBSP | ENO1 | CREBP | PKM | DNAH8 | ||
| CAMK2B | SCN11A | AHSG | AQP11 | ATF4 | ENO2 | CDK2 | TPI1 | MGAM | ||
| CAMK2G | SCN5A | ADAMTS2 | AQP12A | PTH | ENO3 | TP53BP2 | PKLR | ATP1B3 |
List of all proteins that directly and indirectly interact with aluminum. Analyzed by STITCH 5.0 and STRING 10.5 tools.
| STITCH | CALM1 | CALM2 | ATP1A1 | PTH | TF | CAT | GPX1 | NLRP3 | CDK5 | SNCA |
| STRING | MYLK | FGF12 | FXYD4 | PTH2 | TFR2 | ALDH3A2 | GSTT2B | TXNIP | CABLES1 | UCHL1 |
| NOS1 | PPP3CA | FXYD6 | CALCA | HFE | HAO1 | GSTP1 | BRE | MAPT | UBB | |
| NOS2 | CAMK2A | FXYD7 | AVP | ALB | HAO2 | GSTT1 | IL1B | DPYSL2 | SIAH2 | |
| NOS3 | CAMK2B | FXYD2 | SCT | CFTR | ALDH2 | GSTM1 | AIM2 | CDK5R1 | SNCAIP | |
| PPP3CA | NOS3 | FXYD1 | PTH1R | EGF | SOD2 | GSR | NLRC4 | PPP1R1B | PARK2 | |
| PPP3CB | CAMK2G | FXYD3 | PTH2R | EGFR | AKT1 | GSS | PYCARD | CDK5R2 | PARK7 | |
| PPP3CC | SPTAN1 | ATP1B1 | SCTR | APOB | SOD3 | HPGDS | CARD8 | CDK5R1 | SLC6A3 | |
| CAMK2A | SCN10A | ATP1B2 | NPSR1 | RAB5A | SOD1 | SOD1 | CASP1 | NDEL1 | KLK6 | |
| CAMK2B | SCN11A | ATP1B3 | GCG | M6PR | PRDX1 | SOD2 | CASP5 | CCNB1 | APP | |
| CAMK2G | SCN5A | ATP1B4 | PTHLH | TFRC | GSR | SOD3 | NLRP1 | CCNB2 | FYN |
Figure 2Pie graphs demonstrating the GO annotations against the direct protein targets of (a) fluoride and (b) aluminum. The diagrams represent the involvement of the proteins in the biological processes in human. The numbers in the parentheses represent how many GO annotations are present in each different biological process. Results are based on the Blast2GO data mining.
Figure 3Pie diagrams demonstrating the GO annotations against the direct protein targets of (a) fluoride and (b) aluminum. The charts represent the association of the proteins in the molecular functions in human. The numbers in the parentheses represent how many GO annotations are present in each different molecular function. Results are based on the Blast2GO data mining.
Figure 4Pie charts demonstrating the GO annotations against the direct protein targets of (a) fluoride and (b) aluminum. The diagrams represent the involvement of the proteins in the cellular components in human. The numbers in the parentheses represent how many GO annotations are present in each different cellular component. Results are based on the Blast2GO data mining.
Figure 6Pie diagrams demonstrating the GO annotations against the common protein targets of fluoride and aluminum. The charts represent the association of the proteins in the (a) biological processes, (b) cellular components, and (c) molecular functions in human. The numbers in the parentheses represent how many GO annotations are present in each different cellular processes. Results are based on the Blast2GO data mining.
Expression site and expression level of common 19 target proteins on the basis of their RPKM
| Protein | Organ | RPKM |
| MYLK | Prostate | 187.535±50.564 |
| NOS1 | Brain | 1.116±0.49 |
| NOS2 | Small intestine | 10.258±12.184 |
| NOS3 | Spleen | 28.438±5.532 |
| PPP3CA | Brain | 54.022±15.795 |
| PPP3CB | Brain | 40.219±13.441 |
| PPP3CC | Testis | 12.255±3.702 |
| CAMK2A | Brain | 112.156±36.88 |
| CAMK2B | Brain | 44.021±23.5 |
| CAMK2G | Brain | 28.686±4.302 |
| FGF12 | Heart | 20.774±12.935 |
| SPTAN1 | Brain | 87.712±17.558 |
| SCN10A | Testis | 0.0088±0.054 |
| SCN11A | Spleen | 1.852±0.559 |
| SCN5A | Heart | 17.627±3.827 |
| ATP1B2 | Brain | 126.89±28.341 |
| ATP1B3 | Adrenal | 108.403±49.947 |
| ALB | Liver | 41385.4±9345.518 |
| APP | Brain | 395.222±72.782 |
Figure 5The common targets of fluoride and aluminum. The number in the Venn diagram (overlapping portion) represents the common targets. Analyzed by Venny web server.
A short description of the common binding targets of F- and Al with their normal physiological functions.
| Name | Short description | Functions | Reference |
| MYLK | Myosin light chain kinase | Implicated in smooth muscle contraction via phosphorylation of myosin light chains. Involved in inflammatory response and cell migration. Pseudogene of MYLK found having carcinogenic effect. | [ |
| NOS1 | Nitric oxide synthase 1 (neuronal) | Process involved in neurotransmitter biosynthesis and secretion. Polymorphism in this gene has association with neurological disorder and asthma. | [ |
| NOS2 | Nitric oxide synthase 2 (inducible) | Nitric oxide-mediated cell signaling pathway and variation found in asthma patients. | [ |
| NOS3 | Nitric oxide synthase 3 (endothelial cell) | Vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway has association with variation in this gene has association with asthma and Alzheimer disease. | [ |
| PPP3CA | Protein phosphatase 3, catalytic subunit, alpha isozyme | Calcium ion transport, calcinurin-NFAT signaling cascade | [ |
| PPP3CB | Protein phosphatase 3, catalytic subunit, beta isozyme | Calcineurin-NFTA signaling cascade, regulate synaptic spacticity has an association with schizophrenia. | [ |
| PPP3CC | Protein phosphatase 3, catalytic subunit, gamma isozyme | Role in apoptotic signaling pathway has association with schizophrenia. | [ |
| CAMK2A | Calcium/calmodulin dependent protein kinase II alpha | Role in the regulation of synaptic plasticity. Mutation in this gene result in neurological disorder. | [ |
| CAMK2B | Calcium/calmodulin-dependent protein kinase II beta | Regulation of calcium ion transport and synapse structural plasticity. | [ |
| CAMK2G | Calcium/calmodulin-dependent protein kinase II gamma | Involved in sarcoplasmic reticulum Ca2+ transport in skeletal muscle and may function in dendritic spine, synapse formation, and neuronal plasticity. | [ |
| FGF12 | Fibroblast growth factor 12 | Involved in nervous system development and function | [ |
| SPTAN1 | Spectrin, alpha, non-erythrocytic 1 | Calcium-dependent movement of the cytoskeleton at the membrane | [ |
| SCN10A | Sodium channel, voltage-gated, type X, alpha subunit | Mediates the voltage-dependent sodium ion permeability of excitable membranes | [ |
| SCN11A | Sodium channel, voltage-gated, type XI, alpha subunit | Encodes Nav1.9, a voltage-gated sodium ion channel which functions as key relay stations for the electrical transmission of pain signals from the periphery to the central nervous system | [ |
| SCN5A | Sodium channel, voltage-gated, type V, alpha subunit | Responsible for the initial upstroke of the action potential | [ |
| ATP1B2 | ATPase, Na+/K+ transporting, beta 2 polypeptide | Catalyzes the hydrolysis of ATP coupled with the exchange of Na+ and K+ ions across the plasma membrane | [ |
| ATP1B3 | ATPase, Na+/K+ transporting, beta 3 polypeptide | Catalyzes the hydrolysis of ATP coupled with the exchange of Na+ and K+ ions across the plasma membrane | [ |
| ALB | Serum albumin, the main protein of plasma | Regulating the colloidal osmotic pressure of blood | [ |
| APP | Amyloid beta (A4) precursor protein | Triggering caspase activation and degeneration of both neuronal cell bodies and axons | [ |